On the immunopathology of bronchial asthma;Zur immunpathogenese des asthma bronchiale

Pneumologie

Volumn 54, Issue 9, 2000, Pages 412-418

  Finotto, S ^a   Galle, P R ^a   Neurath, M F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CORTICOSTEROID; EOTAXIN;

ALLERGIC REACTION; ASTHMA; BRONCHOSPASM; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; LUNG FIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ASTHMA; BRONCHOCONSTRICTION; CYTOKINES; EOSINOPHILS; HUMANS; INFLAMMATION; MAST CELLS; T-LYMPHOCYTES;

EID: 0033798323     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7185     Document Type: Review

References (68)

1. Klinik des asthma bronchiale
2. Pathogenesis of asthma
3. Rhinitis and asthma
4. Asthma: Clinical descriptions and definitions
5. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis
6. Immunologische grundlagen des asthma bronchiale
7. Nasal polyposis: A model for chronic inflammation
8. Late phase bronchial obstruction following nonimmunologic mast cell degranulation
9. Mast cells and basophils
10. Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients
11. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma
12. Involvement of IL-16 in the induction of airway hyper-responsiveness and regulation of IgE in a murine model of allergic asthma
13. Eosinophils: Biologic and clinical aspects in allergy and inflammation
14. Eosinophilic inflammation in asthma
15. T cells and chronic asthma
16. Essential role of lymphocytes in the development of allergen driven airway hyperresponsiveness
17. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
18. Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E
19. Reduced IL-12 level correlates with decreased 1FN-gamma secreting T cells but not natural killer cell activity in asthmatic children
20. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation
21. Promoter polymorphism in the candidate genes, EL-4, IL-9, TGF-beta 1, for atopy and asthma
22. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma
23. The importance of leukotrienes in airway inflanunation in a mouse murine model of asthma
24. Anti-CD86 (B7-2) treatment abolishes allergic airway hyperresponsiveness in mice
25. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
26. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice
27. Requirement for IL-13 independently of IL-4 in experimental asthma
28. Interleukin-13: Central mediator of allergic asthma
29. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
30. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
31. Direct demonstration of delayed esoinophil apoptosis as a mechanism causing tissue eosinophilia
32. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma
33. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation
34. Cytokines and their receptors as therapeutic targets in asthma
35. A recombinant extrace Hular domain of the human interleukin-4 receptor inhibits the biological effects of interleukin-4 on T and B lymphocytes
36. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation
37. STAT-6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T-cells
38. Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T-cells that respond to bacterial antigens
39. Alveolar macrophage interleukin (EL)-10 and IL-12 production in atopic asthma
40. Administration of interleukin-12 prevents mite Der pl allergen-1gE antibody production and airway eosinophil infiltration in an animal model of airway inflammation
41. Prevention of Th2-like cell responses by coadministration of EL-12 and EL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels
42. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyper-reactivity but cause severe airway inflammation
43. Bee venom immunotherapy results in decrease of IL-4 and EL-5 and increase of IFN-gamma secretion in specific allergen stimulated T cell cultures
44. Therapeutic potential of anti-IgE antibodies
45. The role of 5-lipoxygenase products in preclinical models of asthma
46. Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness
47. Expansion of cytoldne-producing CD4-CD8-T cells associated with abnormal Fas expression and hypereosinophilia
48. Disruption of Fas receptor signaling by nitric oxide in eosinophils
49. Role of T-helper 2 cytokines in down-modulation of fas mRNA and receptor on the surface of activated CD4+ T-cells: Molecular basis for the persistence of the allergic immune response
50. Steroid hormone receptors: Many actors in search of a plot
51. Immunosuppression by glucocorticoids: Inhibition of NF-kB activity through induction of IkB synthesis
52. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids
53. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-Idt ligand, stem cell factor, by resident cells. In vitro and in vivo evidence in murine systems
54. DNA Antisense therapy for asthma in an animal model
55. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
56. Long terin prevention of allergic lung inflanunation in a mouse model of asthma by CpG oligonucleotides
57. Bacterial DNA as immune cell activator
58. CpG oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells
59. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
60. A placebo-controlled trial of ICAM-1 Antisense oligonucleotide in the treatment of Crohn's disease
61. Recent advances in the application of gene therapy to human disease
62. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo
63. Delivery of an adenovirus vector in a calcium phosphate coprecipitate enhances the therapeutic index of gene transfer to airway epithelia
64. Adenoviral infection inhibits allergic airways inflammation in mice
65. Transcription factors in asthma
66. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids
67. IL-4-induced immune deviation as antigen-specific therapy for inflanunatory autoimmune disease